These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 8152567)
1. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations]. De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567 [TBL] [Abstract][Full Text] [Related]
2. Paradoxical growth hormone response to thyrotropin-releasing hormone in acromegaly. Clinical correlations and prognostic value. De Marinis L; Mancini A; Zuppi P; Anile C; Maira G Acta Endocrinol (Copenh); 1990 Apr; 122(4):443-9. PubMed ID: 2110409 [TBL] [Abstract][Full Text] [Related]
3. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly]. Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920 [TBL] [Abstract][Full Text] [Related]
4. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients. De Marinis L; Mancini A; Zuppi P; Fiumara C; Conte G; Sammartano L; Fabrizi ML; Valle D Exp Clin Endocrinol Diabetes; 1996; 104(1):67-71. PubMed ID: 8750573 [TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses. Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339 [TBL] [Abstract][Full Text] [Related]
6. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly. Watanobe H; Tamura T; Sasaki S; Takebe K Neuropeptides; 1993 Dec; 25(6):363-75. PubMed ID: 8127416 [TBL] [Abstract][Full Text] [Related]
7. Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administration. Candrina R Recenti Prog Med; 1991 Jan; 82(1):13-6. PubMed ID: 1902962 [TBL] [Abstract][Full Text] [Related]
8. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue. Peracchi M; Molteni N; Cantalamessa L; Bardella MT; Peracchi G; Orsatti A; Faggioli P; Bianchi PA Am J Gastroenterol; 1992 May; 87(5):580-3. PubMed ID: 1595643 [TBL] [Abstract][Full Text] [Related]
10. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly. Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226 [TBL] [Abstract][Full Text] [Related]
11. TRH/GnRH test in acromegaly. Long-term follow-up experience with successfully treated patients. Brockmeier SJ; Buchfelder M; Fahlbusch R Horm Metab Res; 1993 May; 25(5):275-7. PubMed ID: 8330864 [TBL] [Abstract][Full Text] [Related]
12. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas. Chang CC; Chen FW; Hsieh HC Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734 [TBL] [Abstract][Full Text] [Related]
13. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients. De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia. Le Moli R; Endert E; Fliers E; Prummel MF; Wiersinga WM Neth J Med; 2003 Feb; 61(2):44-8. PubMed ID: 12735420 [TBL] [Abstract][Full Text] [Related]
15. [Surgical results and clinical analysis of 19 cases of acromegaly]. Sugimoto S; Abe H; Kaneko S; Tokuda K; Aida T; Tsuru M; Nakagawa K; Akikawa K; Matsubara M Hokkaido Igaku Zasshi; 1985 Mar; 60(2):241-51. PubMed ID: 3997057 [TBL] [Abstract][Full Text] [Related]
16. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly. Hanew K; Aida M; Tano T; Yoshinaga K Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727 [TBL] [Abstract][Full Text] [Related]
17. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors. Shi Y; Tang D; Deng J; Su C Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233 [TBL] [Abstract][Full Text] [Related]
18. [Normalization of the GH response to L-DOPA in acromegalics after treatment with bromocriptine]. Carmina E; Lanzara P; Lo Coco R; Longo RA; Jannì A Arch Sci Med (Torino); 1979; 136(3):421-5. PubMed ID: 549547 [TBL] [Abstract][Full Text] [Related]
19. Gsp mutation in acromegaly and its influence on TRH-induced paradoxical GH response. Goto Y; Kinoshita M; Oshino S; Arita H; Kitamura T; Otsuki M; Shimomura I; Yoshimine T; Saitoh Y Clin Endocrinol (Oxf); 2014 May; 80(5):714-9. PubMed ID: 24111551 [TBL] [Abstract][Full Text] [Related]